Closing #PCCS2026 with GLP-1s and lifestyle medicine.
The message for primary care: match treatment to the individual, support sustainable lifestyle change and think beyond weight alone to wider cardiometabolic health.
@pccs.bsky.social
@pccs.bsky.socialClosing #PCCS2026 with GLP-1s and lifestyle medicine.
The message for primary care: match treatment to the individual, support sustainable lifestyle change and think beyond weight alone to wider cardiometabolic health.
@pccs.bsky.socialClosing Day 1 at #PCCS2026 with one clear message: heart, kidney & vascular risk can’t be managed in silos. Check eGFR + uACR, recognise PAD and use every diagnosis to address wider cardiovascular risk.
Connect the dots.
@pccs.bsky.socialLive at #PCCS2026: CVD remains under-recognised and under-treated in women. Pregnancy complications, gestational diabetes and early menopause are important cardiovascular risk markers.
Prevention starts by asking the right questions.
@pccs.bsky.socialLive at #PCCS2026: innovation in CVD care isn't about more clinics, it's about smarter prevention.
Use data to find risk earlier, empower MDTs, support home monitoring and move from reactive care to proactive prevention.
@pccs.bsky.socialLive at #PCCS2026: four nations, one clear message. Find CVD risk earlier, treat to target and focus support where need is greatest.
For primary care, prevention must become systematic, proactive and equitable.
